 |
|
Secondary renal tubular dysgenesis in a newborn exposed to angiotensin Ⅱ receptor antagonist during gestation
Mi Hyeon Gang, Yong Wook Lee, Mea-young Chang
Clin Exp Pediatr. 2021;64(3):136-138. Published online 2020 Jul 21 DOI: https://doi.org/10.3345/cep.2020.00752
|
|
Citations to this article as recorded by
 Diagnostic Challenges of Inherited Renal Tubular Dysgenesis
Michelle Joy Wang, Christhian A. Cano‐Guerra, Drucilla J. Roberts, Lydia Shook, Sarah N. Bernstein, Teresa Victoria, Paul K. Fadakar, Megan Aurora, Brian G. Skotko
American Journal of Medical Genetics Part A.2025;[Epub] CrossRef Practical Approach to Congenital Anomalies of the Kidneys: Focus on Anomalies With Insufficient or Abnormal Nephron Development: Renal Dysplasia, Renal Hypoplasia, and Renal Tubular Dysgenesis
Alexia Gazeu, Sophie Collardeau-Frachon
Pediatric and Developmental Pathology.2024; 27(5): 459. CrossRef Angiotensin receptor blocker induced fetopathy: two case reports and literature review
Jinwoon Joung, Heeyeon Cho
Childhood Kidney Diseases.2023; 27(2): 121. CrossRef Sustained activation of the renin–angiotensin–aldosteron system after fetal exposure to AT1 blockers: Effects on kidney and bone in a preterm newborn
Gabriele D'Amato, Georgios Rembouskos, Rosa Cafagna, Domenico Dentico, Stefano Palladino, Mariangela Chiarito, Maria Felicia Faienza
Journal of Obstetrics and Gynaecology Research.2022; 48(12): 3331. CrossRef Inhibition of the renin-angiotensin system during fetal kidney development
Eujin Park
Clinical and Experimental Pediatrics.2021; 64(3): 121. CrossRef Multiple drugs
Reactions Weekly.2021; 1877(1): 289. CrossRef
|